Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Prevalence of high anti tissue transglutaminase (TTG) antibody levels among ‘at high risk’ population in north India
 

amlodipin 5 mg

amlodipin
Ajit Sood1, Parneet Wander1, Kirandeep Kaur2, Ramit Mahajan2, Kriti Sood3, Vandana Midha4
1Department of Gastroenterology, 2Department of Pharmacology, 3Department of Paediatrics, 4Department of Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab.


Corresponding Author
:
Ajit Sood
Email: ajitsood10@gmail.com


Abstract

Background: Although prevalence of celiac disease (CD) is known from the western population, there is a lack of epidemiological data from India. This study aimed at determining the prevalence of CD among at high risk population in India. 
Study Design: Patients considered to be at high risk for CD i.e. those presenting with iron deficiency anemia (IDA) or type 1 diabetes mellitus (T1DM) or infertility or idiopathic generalized epilepsy (IGE) or the first-degree relatives of patients of CD were enrolled in the study. The study was conducted in a tertiary care of hospital with enrollment period from September 2012 to August 2013. They were screened for CD and anti tissue transglutaminase (tTG) antibody levels; and those who tested positive and consented, underwent endoscopic duodenal biopsy for confirmation. 
Results: Prevalence of high anti-tTG was found in 27.3% of  IDA patients, 4.3% among patients with T1DM, 12.8% of infertile female patients, 3% of the patients with IGE and 23.4% of the first degree relatives. Prevalence of villous atrophy was found in 4% of patients with IDA, 4.3% among those with T1DM, 1.8% among infertile female patients and 3% among patients with IGE. None of the first degree relatives consented for intestinal biopsy. 
Conclusion: Prevalence of CD was high among patients presenting with IDA, T1DM and IGE. Prevalence couldn’t be calculated in first degree relatives because of non-consenting patients. Better awareness among both patients and physicians is required in our country.